STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. EPIX
  4. [EFFECT] ESSA Pharma Inc. SEC Filing

[EFFECT] ESSA Pharma Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 14, 2025
Accession Number: 0001104659-25-099619
Submission Type: POS AM
CIK: 0001633932
Company Name: ESSA Pharma Inc.
File Number: 333-274584

Source: View Original Filing on SEC EDGAR

Stock EPIX logo
Essa Pharma

NASDAQ:EPIX

EPIX Rankings

#6277 Ranked by Market Cap
#2184 Ranked by Dividends

EPIX Latest News

Oct 9, 2025
ESSA Announces Completion of Arrangement with XenoTherapeutics
Oct 6, 2025
ESSA Securityholders Approve Acquisition by XenoTherapeutics
Sep 30, 2025
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
Sep 24, 2025
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Sep 10, 2025
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025

EPIX Latest SEC Filings

Oct 15, 2025
[4] – Parkinson David Ross (CIK 0001451935)
Oct 15, 2025
[4] – Wood David S. (CIK 0001826902)
Oct 15, 2025
[4] – BERGER FRANKLIN M (CIK 0001273885)
Oct 15, 2025
[4] – Glickman Richard M (CIK 0001352637)
Oct 15, 2025
[4] – Requadt Scott (CIK 0001664852)

EPIX Stock Data

9.52M
44.65M
5.64%
74.16%
7.74%
Biotechnology
Pharmaceutical Preparations
Link
Canada
VANCOUVER